Methods for generating T lymphocytes from hematopoietic stem cells
This disclosure describes methods for differentiating T cells and NK cells in vitro from hematopoietic stem cells or precursor cells. The technology is directed to methods for the production of selected populations of lymphocytes, such as T cells and NK cells. The availability of such cell populations allows for the complete reconstitution of a depleted, defective or missing lymphocyte population in a patient.
1. A method for differentiating mammalian T cells in vitro, the method comprising:
culturing hematopoietic stem cells, hematopoietic progenitor cells, or both hematopoietic stem cells and hematopoietic progenitor cells in a first culture medium for a sufficient time to produce progenitor T cells, wherein the first culture medium lacks ascorbate and comprises cells modified to express a notch ligand configured to direct differentiation of T cells;
transferring the progenitor T cells to a second culture medium comprising ascorbate; and
culturing the progenitor T cells in the second culture medium for a sufficient time to produce differentiated T cells from the progenitor T cells.
2. The method of claim 1 , wherein the first culture medium comprises minimal essential medium (MEM) as the basal culture medium.
3. The method of claim 1 , wherein the first culture medium comprises Iscove's Modified Dulbecco's Medium (IMDM) as the basal culture medium.
4. The method of claim 1 , wherein the second culture medium comprises alpha modification MEM (αMEM) as the basal culture medium.
5. The method of claim 1 , wherein the cells modified to express a notch ligand comprise OP9-DL1 cells.
6. The method of claim 1 , wherein the cells are cultured in the first culture medium for less than about 30 days.
7. The method of claim 1 , wherein the progenitor T cells are cultured in the second culture medium for at least 7 days to produce differentiated T cells from the progenitor T cells.
8. The method of claim 1 , wherein the ascorbate is phosphoascorbate.
9. The method of claim 1 , wherein the ascorbate is present in an effective amount to preferentially differentiate T cells over NK cells.
10. The method of claim 1 , wherein the amount of ascorbate in the second culture medium is from about 10-1000 μg/mL.
11. The method of claim 1 , wherein the first culture medium comprises IL-7, Flt3 ligand, or both IL-7 and Flt3 ligand.
12. The method of claim 1 , wherein the hematopoietic stem cells, the hematopoietic progenitor cells, or both the hematopoietic stem cells and the hematopoietic progenitor cells express CD34.
13. The method of claim 1 , wherein the first culture medium and the second culture medium lack nucleosides.